Breath Training Devices Market

How big is breath training devices market size?

USD 1.2 billion in 2026 and USD 2.7 billion by 2036 at an 8.4% CAGR.

Demand for Breath Training Devices is projected to expand at 8.4% CAGR between 2026 and 2036, increasing valuation from USD 1.2 billion in 2026 to USD 2.7 billion by 2036. Patients actively deploy inspiratory and expiratory breathing trainers to speed up post-operative recovery and support guided home therapy programs. Andrawes and co-authors described 3 distinct commercial device mechanisms during May 2026 by categorizing them into threshold loading along with flow resistance, and isocapnic hyperpnea. These fundamental mechanical differences directly dictate the type of user feedback required and guide how medical researchers evaluate overall respiratory device performance.

Regional sourcing strategies also shift noticeably depending on local clinical training cultures and healthcare infrastructure. Healthcare buyers across the United States and Germany favor equipment providing calibrated loading records with formal clinician-led reviews. Purchasing groups in Japan and Australia actively prioritize compact portable systems adapting easily to both, everyday rehabilitation and athletic performance programs. Brown and co-authors randomized 90 study participants between app-supported home rehabilitation and traditional center-based care during March 2026. Their clinical trial revealed equivalent exercise-capacity improvements across both patient groups and confirmed the viability of guided home breathing programs whenever users possess basic device skills and receive adequate clinician support.

Key Takeaways for Breath Training Devices Market

• Demand for breath training devices is driven by home rehabilitation and performance conditioning requiring measurable respiratory-muscle progress.
• Mechanical resistance technology is set to garner 41.0% share of technology in 2026, helped by simple loading control and familiar training routines.
• Medical device distributors are predicted to lead distribution channel with 38.0% share in 2026, backed by hospital access and local product support.
• Variable adherence and inconsistent outcome measurement represent principal barriers limiting repeat purchases and clinician confidence.
• Competition focuses on POWERbreathe International Ltd., Airofit A/S, PN Medical, Inc., Aspire Respiratory Products, Medline Inc., ICU Medical, Inc., AirPhysio Pty Ltd., and DOJO Health, Inc.

Analyst Perspective

“Breath training devices gain acceptance when clinicians can set suitable resistance and verify improvement across repeated sessions. Poor adherence weakens results and reduces confidence in continued use. Suppliers need dependable progress tracking and practical follow-up support to help users complete prescribed programs.”

- Anurag Sharma, Principal Analyst for Healthcare at Future Market Insights

How is breath training devices market segmented?

The breath training devices industry is segmented by product type, application, end user, distribution channel, technology, and region.

The breath training devices market is segmented by product type, application, end user, distribution channel, technology, and region. Product Type coverage includes Inspiratory Muscle Training (IMT) Devices, Expiratory Muscle Training (EMT) Devices, Combined IMT/EMT Devices, Breathing Exercisers, and Smart Breath Training Devices. Application coverage addresses Respiratory Rehabilitation, Sports & Fitness, Post-Operative Recovery, Pulmonary Disease Management, and Wellness & Preventive Care. End User coverage spans Hospitals, Homecare Settings, Sports & Fitness Centers, Rehabilitation Centers, and Specialty Clinics. Distribution Channel coverage includes Medical Device Distributors, Direct Sales, Online Retail, Pharmacies & Drug Stores, and Specialty Medical Stores. Technology coverage comprises Mechanical Resistance Technology, Electronic Feedback Technology, Pressure Threshold Technology, Smart Connected Technology, and Sensor-Based Monitoring. Regional coverage includes North America, Europe, East Asia, South Asia and Pacific, Latin America, Middle East and Africa.

Why do inspiratory muscle training (IMT) devices lead product type demand?

Inspiratory muscle training (IMT) devices apply controlled resistance during inhalation, helping users train respiratory muscles through repeatable sessions. Aktan and co-authors studied 30 participants across standard and warm-up groups in January 2025, documenting improved exercise capacity and inspiratory strength following an 8-week program. Findings support calibrated respiratory trainer use across supervised rehabilitation.

• Inspiratory muscle training (IMT) devices are predicted to represent 37.0% share of product type in 2026, driven by direct loading of weakened inspiratory muscles. Clinical teams review training frequency and completion records during device selection.
• Expiratory muscle training (EMT) devices and combined IMT/EMT devices influence swallowing assistance and balanced respiratory conditioning. Breathing exercisers and smart breath training devices address simpler recovery routines or feedback-led consumer programs.

How does respiratory rehabilitation shape application demand?

Respiratory rehabilitation combines exercise and structured breathing practice across chronic disease programs. NHS England reported 61.0% of enrolled pulmonary rehabilitation patients completed discharge assessment in February 2024, showing meaningful completion gaps despite established clinical pathways. Device selection favors manageable resistance and documented progress.

• Based on application, respiratory rehabilitation is anticipated to account for 34.0% share in 2026 due to routine use across COPD and asthma management programs. Clinician acceptance rises with measurable pressure gains and dependable patient follow-through.
• Sports & fitness and wellness & preventive care emphasize breathing control and convenient self-guided routines. Post-operative recovery and pulmonary disease management require closer supervision, especially for frail patients or complex respiratory conditions.

What supports hospitals across end user demand?

Hospitals connect diagnosis and outcome review within one care setting. American Hospital Association counted 6,100 hospitals across United States in February 2026, demonstrating extensive institutional coverage for respiratory assessment and recovery programs. Hospital use favors products carrying calibrated settings and dependable supply.

• By end user, hospitals are set to represent 36.0% share in 2026 owing to by post-operative breathing exercises and pulmonary rehabilitation pathways. Clinical oversight helps match resistance levels with patient capacity and recovery goals.
• Homecare settings and rehabilitation centers extend repeated training beyond acute treatment. Sports & fitness centers and specialty clinics emphasize performance coaching or focused respiratory support, creating distinct service expectations.

Why do medical device distributors lead distribution channel demand?

Medical device distributors connect manufacturers with hospitals and rehabilitation providers requiring local inventory and product education. POWERbreathe reported availability across more than 50 countries during 2026, illustrating distribution depth supporting respiratory muscle training access. Local representation improves product comparison, replacement access, and training assistance.

• In 2026, medical device distributors are expected to secure 38.0% share as it is driven by established hospital relationships and multi-brand respiratory portfolios. Regional stock and technical assistance reduce purchasing delays across clinical accounts.
• Direct sales and online retail support specialist products requiring demonstration or consumer education. Pharmacies & drug stores and specialty medical stores serve convenient replacement demand.

What supports mechanical resistance technology within technology demand?

Mechanical resistance technology provides adjustable loading without complex electronics, supporting straightforward training routines and durable product design. Airofit reported in February 2026 that ELITE users applied breath-hold sessions and received posture alerts during training. Connected guidance illustrates how resistance-based devices increasingly combine physical loading with digital feedback across rehabilitation and performance programs.

• Mechanical resistance technology is likely to capture 41.0% share in 2026, backed by familiar operation and controlled resistance settings. Spring and valve systems support repeatable sessions without extensive setup requirements.
• Electronic feedback technology and smart connected technology add progress tracking and session records. Pressure threshold technology and sensor-based monitoring serve users requiring calibrated loading or quantified airflow assessment.

What are drivers, restraints, and opportunities in breath training devices market?

Chronic respiratory conditions support demand across clinical rehabilitation and guided home programs. Irregular practice reduces therapeutic value and weakens repeat purchasing.

• Driver: Home rehabilitation programs expand demand for calibrated breath trainers by extending guided respiratory-muscle practice beyond hospitals into supervised recovery routines. Clinicians favor devices combining adjustable resistance with simple progress records, since documented improvement supports continuation across chronic care and post-operative programs.
• Restraint: Irregular session completion weakens treatment consistency and reduces confidence in outcomes recorded across unsupervised home-based breathing programs. Providers face longer review cycles if prescriptions lack clear loading targets, leaving buyers uncertain about repeat use and measurable clinical benefit.
• Opportunity: Connected coaching creates an expansion route by pairing resistance exercises with reminders and progress summaries across rehabilitation and performance settings. Supplier platforms offering clinician review and user feedback may strengthen completion rates, improving repeat engagement without adding complex operating demands.

Chronic respiratory disease creates sustained need for breathing support and rehabilitation. National Center for Health Statistics reported COPD among 7.0% of United States adults aged 45 years and older during 2024 in its April 2026 release. Prevalence across older populations supports respiratory-muscle assessment, and structured training pathways.

Unsupervised practice creates a major execution barrier. Dosbaba and co-authors randomized 52 patients in August 2025, finding adherence declined during an unsupervised phase despite maintained benefits within one intervention group. Commercial programs need progress review and clear responsibility for follow-up.

Connected education and measured progress create a practical expansion route. PN Medical reported almost 2,000,000 people reached by its respiratory products as of January 2024, illustrating sizable demand for evidence-led training outside specialist facilities. Providers pairing breathing exercise devices with guided protocols may improve completion and repeat engagement.

How are country CAGRs aligned in breath training devices market?

Country or Market	CAGR
USA	10.7%
Germany	9.9%
Japan	9.0%
UK	8.1%
Canada	7.6%
Australia	7.3%
South Korea	6.9%

Source: Future Market Insights analysis, 2026.

How do country-level CAGRs compare in breath training devices market?

Country comparison shows a gradual step-down across profiled markets. The United States occupies upper forecast position, followed by Germany and Japan. The United Kingdom and Canada form middle-to-lower positions. Australia and South Korea complete disclosed comparison. A 3.8 percentage-point spread separates United States from South Korea. Profiled rates reflect different clinical pathways and home-program readiness.

• The United States is anticipated to lead disclosed comparison based on extensive hospital coverage and home rehabilitation interest.
• Germany is likely to follow under structured clinical review and established rehabilitation facilities.
• Japan is expected to occupy next position led by specialist oversight and compact home-training routines.
• The United Kingdom and Canada are projected to form a middle band shaped by rehabilitation access and service capacity.
• Australia and South Korea complete comparison through connected care models and distributed patient support.

Markets carrying similar CAGRs are likely to present different entry conditions through clinical referral and adherence management. Full report coverage includes North America, Europe, East Asia, South Asia and Pacific, Latin America, Middle East and Africa.

Country-wise Analysis

• Sales in the United States sales are projected to expand at 10.7% CAGR from 2026 to 2036, driven by extensive respiratory care capacity and rising home-program interest. National Center for Health Statistics recorded diagnosed COPD among 4.2% of adults during 2024, sustaining assessment and rehabilitation needs across care settings. Distributor education and program-completion records influence repeat purchasing across hospital and home channels.
• German Federal Statistical Office counted 1,874 hospitals as of September 2024, supporting institutional access for respiratory assessment and recovery pathways. Local documentation and calibrated loading records guide adoption across hospitals and rehabilitation facilities. Demand in Germany is anticipated to rise at 9.9% CAGR by 2036, influenced by clinical review and rehabilitation infrastructure.
• Specialist oversight and compact equipment help transfer structured practice into Japanese home routines. Adoption in Japan is estimated to grow at 9.0% CAGR between 2026 and 2036, led by measured respiratory-muscle assessment. Shiraishi and co-authors enrolled 38 participants in an inspiratory muscle training trial published during November 2024, reinforcing clinical interest in diaphragm function and exercise tolerance.
• Sector in the United Kingdom is likely to increase at 8.1% CAGR during the study period, guided by demand for scalable guided rehabilitation. Royal College of Physicians reported a 100-day average wait for stable COPD patients starting pulmonary rehabilitation in June 2026, exposing service-capacity pressure. Home programs need clinician review and simple adherence reporting across constrained pathways.
• Canadian Institute for Health Information reported 7.0 days average hospital stay for COPD and bronchitis during 2024- 2025, highlighting recovery burdens extending beyond acute treatment. Provincial coverage and dependable training guidance influence uptake across home and rehabilitation channels. Industry in Canada is forecast to scale at 7.6% CAGR during the assessment period, backed by chronic respiratory admissions and dispersed service delivery.
• Geographic distance and specialist hubs encourage connected instruction with remote progress review across Australia. The market in Australia is anticipated to rise at 7.3% CAGR by 2036, helped by distributed respiratory-care needs. Australian Institute of Health and Welfare recorded 61,500 emergency department presentations due to COPD during 2024 to 2025 in its February 2026 update, highlighting substantial acute-care activity.
• Sales in South Korea are projected to record 6.9% CAGR between 2026 and 2036, aided by connected rehabilitation and technology-oriented care delivery. Kim and co-authors conducted a pulmonary rehabilitation trial across 3 centers in April 2024, demonstrating institutional capacity for app-guided respiratory programs. Localized coaching and measurable progress influence product acceptance across clinician-led pathways.

Who are notable companies in breath training devices market?

POWERbreathe International Ltd., Airofit A/S, PN Medical, Inc., Aspire Respiratory Products, Medline Inc., ICU Medical, Inc., AirPhysio Pty Ltd., and DOJO Health, Inc. are notable companies active in breath training devices.

Competition in the market centers on loading precision and channel reach. Respiratory muscle training specialists emphasize adjustable resistance and progress measurement. Hospital suppliers compete based on disposable exercisers and familiar clinical workflows. Connected challengers add session records and real-time breath metrics. Buyer review covers replacement access and program-completion support.

• POWERbreathe International Ltd. and Airofit A/S compete driven by inspiratory training and guided performance feedback. Buyers compare coaching quality and compatibility with clinical or athletic programs.
• PN Medical, Inc. and Aspire Respiratory Products focus on combined or expiratory muscle training supported by established protocols. Clinicians assess patient suitability and evidence covering cough or endurance.
• Medline Inc. and ICU Medical, Inc. serve hospital respiratory workflows led by incentive exercisers and airway-care portfolios. Institutional buyers emphasize simple operation and staff familiarity.
• AirPhysio Pty Ltd. and DOJO Health, Inc. address different entry routes depending on expiratory lung expansion and connected breath tracking. Product evaluation reflects intended setting and user-support requirements.

Competitive Benchmarking: Breath Training Devices Market

Company	Training Mechanism	Feedback Capability	Clinical Channel	Commercial Reach
POWERbreathe International Ltd.	High	High	High	Global
Airofit A/S	High	High	Medium	International
PN Medical, Inc.	High	Medium	High	International
Aspire Respiratory Products	High	Low	High	International distributors
Medline Inc.	Medium	Low	High	Global
ICU Medical, Inc.	Medium	High	High	Global
AirPhysio Pty Ltd.	Medium	Low	Medium	International
DOJO Health, Inc.	Medium	High	Emerging	Early commercial rollout

Source: Future Market Insights competitive analysis, 2026.

Key Developments in Breath Training Devices Market

• In May 2025, ICU Medical and VisionHealth launched MyAcapella, adding guided therapy, reminders, education, and adherence tracking for respiratory patients. Coaching support strengthens completion oversight across prescribed airway-clearance routines.
• In January 2026, DOJO Health announced a Golden State Storm partnership for respiratory performance hardware and breath tracking. Athlete integration extends measured breath training into structured team-performance programs.
• In May 2026, DOJO Health launched DOJO Air through Kickstarter as a volumetric breath training and tracking platform. Real-time volume, airflow, and breath-hold feedback create a measurable consumer training pathway.

Key Players in Breath Training Devices Market

Respiratory Muscle Training Specialists

• POWERbreathe International Ltd.
• Airofit A/S
• PN Medical, Inc.
• Aspire Respiratory Products

Clinical Respiratory Device Providers

• Medline Inc.
• ICU Medical, Inc.
• AirPhysio Pty Ltd.

Connected Breath Training Challenger

• DOJO Health, Inc.

Breath Training Devices Market Report Scope

Coverage field	Report scope
Market breakdown	Breath training devices market breakdown includes product type, application, end user, distribution channel, technology, and region.
Quantitative Units	USD billion in 2026 to USD billion by 2036 at CAGR
Market Definition	Breath training devices include inspiratory and expiratory muscle trainers, combined resistance products, incentive exercisers, connected coaching tools, and related rehabilitation products. Generic wellness applications lacking a physical training device are excluded.
Regions Covered	North America, Europe, East Asia, South Asia and Pacific, Latin America, Middle East and Africa.
Countries Covered	USA, Germany, Japan, UK, Canada, Australia, South Korea, and additional countries covered across full regional analysis.
Key Companies Profiled	POWERbreathe International Ltd., Airofit A/S, PN Medical, Inc., Aspire Respiratory Products, Medline Inc., ICU Medical, Inc., AirPhysio Pty Ltd., and DOJO Health, Inc.
Forecast Period	2026 to 2036
Approach	Hybrid bottom-up and top-down methodology uses segment shares and country CAGRs. Company activity, clinical pathways, distributor reach, and user adherence support final reconciliation.

Source: Future Market Insights analysis, 2026.

Breath Training Devices Market - Research Methodology

Method	Approach
Primary Research	FMI analysts gathered input from manufacturers, service providers, technology developers, distributors, end users, procurement teams, and subject-matter experts. Interviews examined purchasing decisions, product or service evaluation, adoption barriers, approval requirements, pricing considerations, and expectations for technical or commercial support. Respondents were also asked what evidence is required before a trial, pilot, or initial order develops into regular purchasing.
Desk Research	Desk research covered government statistics, regulatory publications, trade data, industry associations, technical literature, standards, company filings, product information, and official corporate announcements. Sources were reviewed for relevance, publication date, geographic coverage, and consistency with the defined market scope. Claims relating to performance, applications, approvals, capacity, investment, and commercial activity were retained only when supported by credible public evidence.
Market Sizing and Forecasting	The market model combined the baseline value with historical performance, segment structure, pricing and volume indicators, adoption levels, company participation, and country-level demand conditions. Forecast assumptions considered economic activity, investment trends, regulatory developments, technology adoption, purchasing cycles, supply availability, and barriers to wider market use. Segment and regional estimates were reconciled before the final market total was calculated.
Data Validation	Estimates were checked against multiple independent indicators, including public data, company activity, trade patterns, industry developments, and findings from primary interviews. Validation also tested whether products, services, applications, and company revenues fell within the defined market boundaries. Adjacent categories, unsupported claims, overlapping revenues, and activities without direct market relevance were excluded to reduce double counting and maintain consistency across segments and countries.

Source: Future Market Insights analysis, 2026.

Breath Training Devices Market by Segments

Breath Training Devices Market segmented by Product Type:

• Inspiratory Muscle Training (IMT) Devices
• Expiratory Muscle Training (EMT) Devices
• Combined IMT/EMT Devices
• Breathing Exercisers
• Smart Breath Training Devices

Breath Training Devices Market segmented by Application:

• Respiratory Rehabilitation
• Sports & Fitness
• Post-Operative Recovery
• Pulmonary Disease Management
• Wellness & Preventive Care

Breath Training Devices Market segmented by End User:

• Hospitals
• Homecare Settings
• Sports & Fitness Centers
• Rehabilitation Centers
• Specialty Clinics

Breath Training Devices Market segmented by Distribution Channel:

• Medical Device Distributors
• Direct Sales
• Online Retail
• Pharmacies & Drug Stores
• Specialty Medical Stores

Breath Training Devices Market segmented by Technology:

• Mechanical Resistance Technology
• Electronic Feedback Technology
• Pressure Threshold Technology
• Smart Connected Technology
• Sensor-Based Monitoring

Breath Training Devices Market segmented by Region:

• North America
  • United States
  • Canada
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Chile
• Western Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Benelux
  • Nordics
• Eastern Europe
  • Poland
  • Czech Republic
  • Romania
  • Hungary
• East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • ASEAN
  • Australia and New Zealand
• Middle East and Africa
  • GCC Countries
  • South Africa
  • Türkiye
  • Israel

Research Sources and Bibliography

• Airofit A/S. (2026, February 5). How breath training supports performance across three disciplines.
• Airofit A/S. (2026, April 30). Terms of sale and service.
• AirPhysio Pty Ltd. (2025, April 29). World Asthma Day: Let’s clear the air together.
• American Hospital Association. (2026, February). Fast facts on USA hospitals, 2026.
• Aspire Respiratory Products. (2026, January 24). 6 Hour Respiratory Muscle Strength Clinical Training Workshop.
• Andrawes, R., Wang, S., Sohrabipour, S., Goligher, E. C., Keshavjee, S., Reid, W. D., & Rozenberg, D. (2026, May 17). Inspiratory muscle training devices for chronic lung disease management: Current evidence and future directions. Expert Review of Medical Devices, 23(6), 633- 646.
• Aktan, R., Özalevli, S., Yakut, H., & Özgen Alpaydin, A. (2025, January). The effects of inspiratory muscle warm-up prior to inspiratory muscle training during pulmonary rehabilitation in subjects with chronic obstructive pulmonary disease: A randomized trial. Physiotherapy Theory and Practice, 41(1), 1- 11.
• Australian Institute of Health and Welfare. (2026, February 18). Chronic respiratory conditions: Chronic obstructive pulmonary disease.
• Brown, S. E., Wootton, S., Dale, M. T., Alison, J. A., Chan, A. S. L., Varnfield, M., Yang, I., Cunich, M., & McKeough, Z. J. (2026, March 13). Mobile health pulmonary rehabilitation (m-PR): A randomised controlled equivalence trial. Thorax, 81(4), 302- 310.
• Canadian Institute for Health Information. (2026, February 19). Hospital stays in Canada, 2024- 2025.
• DOJO Health, Inc. (2026, January 28). The Golden State Storm powers the future of athlete performance through flagship partnership with DOJO Air.
• DOJO Health, Inc. (2026, May 12). DOJO Air debuts on Kickstarter, introducing the world’s first breath training and tracking platform.
• DOJO Health, Inc. (2026, May 5). The DOJO Air breathwork revolution: Meet the device changing how we breathe and perform.
• Dosbaba, F., Hartman, M., Formiga, M. F., Vlazna, D., Mináriková, J., Plutinsky, M., Brat, K., Su, J. J., Cahalin, L. P., & Batalik, L. (2025, August 28). Long-term efficacy of novel and traditional home-based, remote inspiratory muscle training in COPD: A randomized controlled trial. Journal of Clinical Medicine, 14(17), 6099.
• German Federal Statistical Office. (2024, September 27). Medical facilities, hospital beds and movement of patient.
• ICU Medical, Inc. (2025, May 15). ICU Medical and VisionHealth launch MyAcapella digital OPEP coach to improve OPEP therapy and adherence for respiratory patients.
• ICU Medical, Inc. (2025, September 18). News.
• Medline Newsroom Staff. (2024, May 23). Medline introduces high-efficiency medication delivery system to respiratory portfolio.
• Medline Inc. (2026, February 25). Medline reports fourth-quarter and full-year 2025 results.
• Kim, C., Choi, H.-E., Rhee, C. K., Song, J. H., & Lee, J. H. (2024, April 3). Efficacy of digital therapeutics for pulmonary rehabilitation: A multi-center, randomized controlled trial. Life, 14(4), 469.
• National Center for Health Statistics. (2026). Chronic obstructive pulmonary disease: FastStats.
• NHS England. (2024, February 1). Annex: Operational performance update.
• PN Medical, Inc. (2024, January 10). About PN Medical.
• PN Medical, Inc. (2025, August 24). Reduce work-related stress with BREATHER FIT: Clinical evidence from front-line health workers.
• POWERbreathe International Ltd. (2025). Our history.
• POWERbreathe International Ltd. (2026). The story of POWERbreathe.
• Royal College of Physicians. (2026, June 11). Respiratory care improving in key areas, but progress remains uneven, new national clinical audit report shows.
• Shiraishi, M., Higashimoto, Y., Sugiya, R., Mizusawa, H., Takeda, Y., Noguchi, M., Nishiyama, O., Yamazaki, R., Kudo, S., Kimura, T., & Matsumoto, H. (2024, November 25). Enhanced diaphragm excursion and exercise tolerance in COPD patients through inspiratory muscle training after standardised pulmonary rehabilitation: Randomised controlled trial. ERJ Open Research, 10(6), 00035-2024.
• Wang, X., & Black, L. I. (2026, April). Prevalence of selected chronic conditions among adults age 45 and older, by age and urbanization level: United States, 2024. NCHS Data Brief, 557, 1- 12.

This bibliography is provided for reader reference and is not exhaustive. The full report contains the complete reference list and detailed citations.

This Report Answers

• How do product type and technology influence breath training device selection?
• What criteria guide hospitals evaluating respiratory muscle trainers for clinical use?
• Why do country CAGRs differ across profiled breath training device markets?
• What companies compete through resistance control and clinical reach?
• How are forecasts validated through segment shares and independent indicators?
• What evidence supports home rehabilitation adoption across respiratory programs?
• Why do adherence and outcome records influence repeat device purchasing?
• How does distributor coverage affect clinical access and product support?
• What company capabilities improve confidence across rehabilitation and performance programs?
• How do connected coaching tools change breath training program management?